Please assess the completion status of the following clinical trial:

Trial Title: PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age at entry 18-65~* Positive for Hepatitis C~* Nonresponder to previous treatment (minimum of 3 months) with an alpha Interferon plus ribavirin~* Liver biopsy demonstrating moderate to severe fibrosis or cirrhosis~Exclusion Criteria:~* Any cause for the liver disease other than chronic hepatitis C~* History or presence of complications of cirrhosis~* Alcohol or illicit drug use or methadone treatment within the past 2 years~* Treatment for chronic hepatitis C within the previous 6 months~* Diseases or conditions that could interfere with the subject's participation in and completion of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Overall study population (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).